Siena S - Search Results

1

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.

Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Siena S, et al. J Clin Oncol. 2000 Mar;18(6):1360-77. doi: 10.1200/JCO.2000.18.6.1360. J Clin Oncol. 2000. PMID: 10715309 Review.

2

Hematopoietic stem cell transplantation in the treatment of lymphoma.

Bregni M, Siena S. Bregni M, et al. Among authors: siena s. Curr Opin Oncol. 1991 Oct;3(5):838-42. doi: 10.1097/00001622-199110000-00006. Curr Opin Oncol. 1991. PMID: 1684293 Review.

3

Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.

Gianni AM, Siena S, Bregni M, Lombardi F, Gandola L, Valagussa P, Bonadonna G. Gianni AM, et al. Among authors: siena s. Ann Oncol. 1991 Oct;2(9):645-53. doi: 10.1093/oxfordjournals.annonc.a058043. Ann Oncol. 1991. PMID: 1720655 Free article.

4

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.

Gianni AM, Bregni M, Siena S, Orazi A, Stern AC, Gandola L, Bonadonna G. Gianni AM, et al. Among authors: siena s. J Clin Oncol. 1990 May;8(5):768-78. doi: 10.1200/JCO.1990.8.5.768. J Clin Oncol. 1990. PMID: 2185337

5

Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.

Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM. Siena S, et al. Exp Hematol. 1993 Nov;21(12):1583-90. Exp Hematol. 1993. PMID: 7691640

6

Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.

Siena S, Bregni M, Di Nicola M, Ravagani F, Peccatori F, Gandola L, Lombardi F, Tarella C, Bonadonna G, Gianni AM. Siena S, et al. Ann Oncol. 1994 Dec;5(10):935-41. doi: 10.1093/oxfordjournals.annonc.a058733. Ann Oncol. 1994. PMID: 7696166 Free article.

7

High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.

Gianni AM, Tarella C, Bregni M, Siena S, Lombardi F, Gandola L, Caracciolo D, Stern A, Bonadonna G, Boccadoro M, et al. Gianni AM, et al. Among authors: siena s. J Clin Oncol. 1994 Mar;12(3):503-9. doi: 10.1200/JCO.1994.12.3.503. J Clin Oncol. 1994. PMID: 8120548

8

Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.

Siena S, Di Nicola M, Bregni M, Mortarini R, Anichini A, Lombardi L, Ravagnani F, Parmiani G, Gianni AM. Siena S, et al. Exp Hematol. 1995 Dec;23(14):1463-71. Exp Hematol. 1995. PMID: 8542932

9

A standardized flow cytometry protocol for mobilized peripheral CD34+ cells estimation and collection for autotransplantation in cancer patients.

Brando B, Siena S, Bregni M, Gianni AM, Grillo P, Sommaruga E. Brando B, et al. Among authors: siena s. Eur J Histochem. 1994;38 Suppl 1:21-6. Eur J Histochem. 1994. PMID: 8547706 Review. No abstract available.

10

Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.

Bregni M, Siena S, Di Nicola M, Dodero A, Peccatori F, Ravagnani F, Danesini G, Laffranchi A, Bonadonna G, Gianni AM. Bregni M, et al. Among authors: siena s. J Clin Oncol. 1996 Feb;14(2):628-35. doi: 10.1200/JCO.1996.14.2.628. J Clin Oncol. 1996. PMID: 8636780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters